Sarasota, FL, Dec. 26, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography  Carotid Ultrasound, Cerebral Angiography and Others) by Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant) for Haemorrhagic Stroke and Ischemic Stroke - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”.  According to the report, the global stroke diagnostics and therapeutics market accounted for USD 21.50 billion in 2015 and is expected to reach USD 31.00 by 2021, growing at a CAGR of approximately 7.0% between 2015 and 2021.  

Stroke arises due to interruptions in the blood supply to the brain, either due to the rupture or blockage of blood vessels which leads to the death of brain cells. Stroke is one of the major causes of death worldwide, with higher prevalence in the old age population.

Browse through 33 Market Tables and 38 Figures spread over 110 Pages and in-depth TOC on “Global Stroke Diagnostics and Therapeutics Market: By Type, Application, Size, Share, Trends, Analysis, Segment, and Forecast 2015-2021”.

Request free Sample copy of Stroke Diagnostics and Therapeutics Market Report @ https://www.zionmarketresearch.com/sample/stroke-diagnostics-therapeutics-market

According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Hence, there is an impending need for early diagnostic devices and therapeutics to prevent deaths from stroke. Because stroke occurs rapidly and requires immediate treatment, stroke is also called a brain attack. When the symptoms of a stroke last only a short time (less than an hour), this is called a transient ischemic attack (TIA) or mini-stroke.

Stroke diagnostics and therapeutics market have been accelerated by the large patient pool along with rising aging population across the globe. Moreover, increasing the percentage of the geriatric population in western countries especially in Europe is the key driving factor for fueling the growth of stroke diagnostics and therapeutics market. Furthermore, hypertension, atrial fibrillation, and coronary heart diseases are the supporting factors which promote the growth of stroke diagnostics and therapeutics market. However, the high cost of treatment directly affects the growth of stroke diagnostics and therapeutics market. In addition, lack of transparent reimbursement scenario is also likely to impact the growth of stroke diagnostics and therapeutics market. Nonetheless, ongoing research and development in the healthcare sector technologies are expected to open growth avenues for the stroke diagnostics and therapeutics market over the years.

Browse the full "Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography  Carotid Ultrasound, Cerebral Angiography and Others) by Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant) for Haemorrhagic Stroke and Ischemic Stroke - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/stroke-diagnostics-therapeutics-market

Based on diagnostics, the global stroke diagnostics and therapeutics market is segmented into five types: magnetic resonance imaging, computed tomography scan, electrocardiography, carotid ultrasound, cerebral angiography and others.  Magnetic resonance imaging dominates the diagnostic segment of global stroke diagnostics and therapeutics market in 2015. This growth is attributed due to the huge demand of magnetic resonance in treatment or diagnostic of stroke.

Based on therapeutics, the global stroke diagnostics and therapeutics market is segmented into four types: tissue plasminogen activator, antiplatelet, antihypertensive and anticoagulant. Antiplatelet and anticoagulants are the drug of choice for the initial treatment of stroke. Aspirin and warfarin are the drugs included in a therapy for the stroke management therapy.

Based on application, the global stroke diagnostics and therapeutics market is segmented into two types: haemorrhagic stroke and ischemic stroke. Ischemic stroke dominated the application segment of global stroke diagnostics and therapeutics market in 2015. This segment is expected to remain on the hike during the forecast period. The growth is attributed due to huge prevalence of ischemic stroke in elderly age patient when distinguishing with haemorrhagic stroke.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/stroke-diagnostics-therapeutics-market

North America was the dominating region for stroke diagnostics and therapeutics market in 2015. The growth was accredited due to rising awareness amongst the population regarding symptoms of the stroke followed by various harmful effect associated with high glucose level in blood. Moreover, high-end research and technological advancements, increasing public interest are the important key factors which drive the demand for stroke diagnostics and therapeutics market in this region. Higher healthcare expenditure and encouraging healthcare infrastructure in this region are other growth factors for stroke diagnostics and therapeutics market. Stroke is the 5th leading cause of death in the US, with one person dying every 4 minutes. For black Americans, stroke is the 3rd leading cause of death.

In the European Union, there are more than 31 million people living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Furthermore, growing percentage of diabetes mellitus population is directly proportionate to the associated risk of stroke in individuals. Europe was the second largest market for global stroke diagnostics and therapeutics market in 2015. This growth is mainly associated with advancement in technological and healthcare research in this region. 

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/574

The Asia-Pacific region may offer upcoming significant opportunities for the stroke diagnostics and therapeutics market. At present, China and India are the most populous countries in the region contributing to the increased demand for stroke diagnostics and therapeutics market in 2015. China a second largest economy and home to the world’s largest population with close to 1.38 billion inhabitants followed by India with approximately 1.25 billion people in 2014. China and India are considered as a big market for stroke diagnostics and therapeutics market within the forecast period. As a result, many key market players are continuously focusing on penetrating and strengthening their position in this region.

Growing cases obesity, sedentary lifestyle in the Middle East and Africa are likely to fuel the growth of stroke diagnostics and therapeutics market within the forecast period.

The key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/stroke-diagnostics-therapeutics-market

This report segments the global stroke diagnostics and therapeutics market as follows:

Global Stroke Diagnostics and Therapeutics Market: Diagnostics Analysis

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Others

Global Stroke Diagnostics and Therapeutics Market: Therapeutics Analysis

  • Tissue Plasminogen Activator
  • Antiplatelet
  • Antihypertensive
  • Anticoagulant

Global Stroke Diagnostics and Therapeutics Market: Application Analysis

  • Haemorrhagic Stroke
  • Ischemic Stroke

Global Stroke Diagnostics and Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • U.K.
    • Germany
    • France 
  • Asia Pacific
    • China 
    • Japan 
    • India
  • Latin America
    • Brazil
  • Middle East And Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us:

Joel John

4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/